BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27798168)

  • 1. Discrete TCR Binding Kinetics Control Invariant NKT Cell Selection and Central Priming.
    Cruz Tleugabulova M; Escalante NK; Deng S; Fieve S; Ereño-Orbea J; Savage PB; Julien JP; Mallevaey T
    J Immunol; 2016 Nov; 197(10):3959-3969. PubMed ID: 27798168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell Receptors.
    Guo T; Chamoto K; Nakatsugawa M; Ochi T; Yamashita Y; Anczurowski M; Butler MO; Hirano N
    PLoS One; 2016; 11(5):e0156114. PubMed ID: 27213277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.
    Lawson V
    Immunology; 2012 Sep; 137(1):20-7. PubMed ID: 22734667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Protein Phosphatase Shp1 Regulates Invariant NKT Cell Effector Differentiation Independently of TCR and Slam Signaling.
    Cruz Tleugabulova M; Zhao M; Lau I; Kuypers M; Wirianto C; Umaña JM; Lin Q; Kronenberg M; Mallevaey T
    J Immunol; 2019 Apr; 202(8):2276-2286. PubMed ID: 30796181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategy of lipid recognition by invariant natural killer T cells: 'one for all and all for one'.
    Mallevaey T; Selvanantham T
    Immunology; 2012 Jul; 136(3):273-82. PubMed ID: 22671023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
    Gerth E; Mattner J
    Front Immunol; 2019; 10():1449. PubMed ID: 31293596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
    Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
    Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Subset of CD8αβ+ Invariant NKT Cells in a Humanized Mouse Model.
    Wen X; Kim S; Xiong R; Li M; Lawrenczyk A; Huang X; Chen SY; Rao P; Besra GS; Dellabona P; Casorati G; Porcelli SA; Akbari O; Exley MA; Yuan W
    J Immunol; 2015 Aug; 195(4):1459-69. PubMed ID: 26157173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role for invariant chain in CD1d-mediated selection and maturation of Vα14-invariant NKT cells.
    Sillé FC; Martin C; Jayaraman P; Rothchild A; Besra GS; Behar SM; Boes M
    Immunol Lett; 2011 Sep; 139(1-2):33-41. PubMed ID: 21565221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d.
    Almeida CF; Smith DGM; Cheng TY; Harpur CM; Batleska E; Nguyen-Robertson CV; Nguyen T; Thelemann T; Reddiex SJJ; Li S; Eckle SBG; Van Rhijn I; Rossjohn J; Uldrich AP; Moody DB; Williams SJ; Pellicci DG; Godfrey DI
    Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34417291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Innate-like T Cell Development in Vα14-Jα18 TCRα Transgenic Mice.
    Lau I; de Amat Herbozo C; Kuypers M; Lin Q; Paget C; Mallevaey T
    Immunohorizons; 2020 Dec; 4(12):797-808. PubMed ID: 33323387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type II Natural Killer T Cells Contribute to Protection Against Systemic Methicillin-Resistant
    Genardi S; Visvabharathy L; Cao L; Morgun E; Cui Y; Qi C; Chen YH; Gapin L; Berdyshev E; Wang CR
    Front Immunol; 2020; 11():610010. PubMed ID: 33312179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypervariable region 4 (HV4) and position 93 of the α chain modulate CD1d-glycolipid binding of iNKT TCRs.
    Paletta D; Fichtner AS; Hahn AM; Starick L; Beyersdorf N; Monzon-Casanova E; Mueller TD; Herrmann T
    Eur J Immunol; 2015 Jul; 45(7):2122-33. PubMed ID: 25900449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
    Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
    Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural variations at position 93 of the invariant Vα24-Jα18 α chain of human iNKT-cell TCRs strongly impact on CD1d binding.
    Sanderson JP; Waldburger-Hauri K; Garzón D; Matulis G; Mansour S; Pumphrey NJ; Lissin N; Villiger PM; Jakobsen B; Faraldo-Gómez JD; Gadola SD
    Eur J Immunol; 2012 Jan; 42(1):248-55. PubMed ID: 21956730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophospholipid presentation by CD1d and recognition by a human Natural Killer T-cell receptor.
    López-Sagaseta J; Sibener LV; Kung JE; Gumperz J; Adams EJ
    EMBO J; 2012 Apr; 31(8):2047-59. PubMed ID: 22395072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD1d-independent activation of invariant natural killer T cells by staphylococcal enterotoxin B through major histocompatibility complex class II/T cell receptor interaction results in acute lung injury.
    Rieder SA; Nagarkatti P; Nagarkatti M
    Infect Immun; 2011 Aug; 79(8):3141-8. PubMed ID: 21628519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ins and outs of type I iNKT cell development.
    Shissler SC; Webb TJ
    Mol Immunol; 2019 Jan; 105():116-130. PubMed ID: 30502719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
    Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
    Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD1d protein structure determines species-selective antigenicity of isoglobotrihexosylceramide (iGb3) to invariant NKT cells.
    Sanderson JP; Brennan PJ; Mansour S; Matulis G; Patel O; Lissin N; Godfrey DI; Kawahara K; Zähringer U; Rossjohn J; Brenner MB; Gadola SD
    Eur J Immunol; 2013 Mar; 43(3):815-25. PubMed ID: 23280365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.